Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1019.0000 16.70 (1.67%)
NSE Jul 10, 2025 14:52 PM
Volume: 41,883
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
1019.00
1.67%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Alivus Life Sciences Ltd. is trading above its 30 day SMA of 1016.3
More from Alivus Life Sciences Ltd.
Recommended
Market trades lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 02:49PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021